AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 97 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is 0.03 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $12,688,881 | -4.9% | 3,646,230 | +74.4% | 0.15% | +32.7% |
| Q1 2024 | $13,337,205 | +133.9% | 2,090,471 | +136.1% | 0.11% | +135.4% |
| Q4 2023 | $5,702,433 | +65.8% | 885,471 | -40.0% | 0.05% | +128.6% |
| Q3 2023 | $3,439,327 | -3.7% | 1,476,106 | -1.6% | 0.02% | +5.0% |
| Q2 2023 | $3,570,000 | +29.3% | 1,500,000 | 0.0% | 0.02% | +5.3% |
| Q1 2023 | $2,760,000 | -3.2% | 1,500,000 | 0.0% | 0.02% | +46.2% |
| Q4 2022 | $2,850,000 | +225.3% | 1,500,000 | +881.4% | 0.01% | +160.0% |
| Q1 2021 | $876,000 | -19.0% | 152,847 | +126.4% | 0.01% | -58.3% |
| Q2 2020 | $1,082,000 | +52.2% | 67,519 | -43.1% | 0.01% | +50.0% |
| Q1 2020 | $711,000 | -2.6% | 118,734 | +162.0% | 0.01% | +14.3% |
| Q2 2019 | $730,000 | 0.0% | 45,314 | +87.3% | 0.01% | 0.0% |
| Q3 2018 | $730,000 | -63.7% | 24,190 | -67.7% | 0.01% | -56.2% |
| Q2 2018 | $2,009,000 | – | 75,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 7,346,829 | $15,723,000 | 27.32% |
| TFG Asset Management GP Ltd | 3,039,381 | $6,504,000 | 0.78% |
| Nantahala Capital Management | 5,215,788 | $11,162,000 | 0.72% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,018,000 | 0.62% |
| HARBOR CAPITAL ADVISORS, INC. | 148,454 | $318,000 | 0.29% |
| DAFNA Capital Management LLC | 496,150 | $1,062,000 | 0.29% |
| Blackstone Inc. | 17,985,611 | $38,489 | 0.14% |
| Ikarian Capital, LLC | 260,087 | $556,000 | 0.11% |
| MYDA Advisors LLC | 100,000 | $214,000 | 0.10% |
| Privium Fund Management B.V. | 113,528 | $253,000 | 0.09% |